ZEOX Stock Chart & Stats
$1.85
-$0.01(-0.37%)
At close: 4:00 PM EST
$1.85
-$0.01(-0.37%)
Day’s Range― - ―
52-Week Range$1.20 - $2.99
Previous CloseN/A
Volume825.00
Average Volume (3M)21.06K
Market Cap
$14.11M
Enterprise Value$9.31M
Total Cash (Recent Filing)$1.85M
Total Debt (Recent Filing)$96.00K
Price to Earnings (P/E)―
Beta0.44
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.58
Shares Outstanding7,837,441
10 Day Avg. Volume51,743
30 Day Avg. Volume21,062
Financial Highlights & Ratios
PEG Ratio-0.13
Price to Book (P/B)-8.42
Price to Sales (P/S)2.31
P/FCF Ratio-16.18
Enterprise Value/Market Cap0.66
Enterprise Value/Revenue1.33
Enterprise Value/Gross Profit1.63
Enterprise Value/Ebitda-2.49
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Zeo ScientifiX News
ZEOX FAQ
What was Zeo ScientifiX’s price range in the past 12 months?
Zeo ScientifiX lowest stock price was $1.20 and its highest was $2.99 in the past 12 months.
What is Zeo ScientifiX’s market cap?
Zeo ScientifiX’s market cap is $14.11M.
When is Zeo ScientifiX’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Zeo ScientifiX’s earnings last quarter?
Currently, no data Available
Is Zeo ScientifiX overvalued?
According to Wall Street analysts Zeo ScientifiX’s price is currently Overvalued.
Does Zeo ScientifiX pay dividends?
Zeo ScientifiX does not currently pay dividends.
What is Zeo ScientifiX’s EPS estimate?
Zeo ScientifiX’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Zeo ScientifiX have?
Zeo ScientifiX has 7,837,441 shares outstanding.
What happened to Zeo ScientifiX’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Zeo ScientifiX?
Currently, no hedge funds are holding shares in ZEOX
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Zeo ScientifiX
Zeo ScientifiX, Inc. is a clinical-stage biopharmaceutical company specializing in developing biological therapeutics aimed at treating degenerative diseases and fostering regenerative medicine. Its flagship investigational product, Zofin, is an acellular biologic therapy sourced from perinatal materials. This candidate is currently in Phase I/II clinical trials, evaluating its efficacy for COVID-19, chronic obstructive pulmonary disease (COPD), and knee osteoarthritis. The company's portfolio also includes Patient Pure X, an autologous, blood-derived biologic technology designed to enhance the body's natural capacity to reduce cellular inflammation and promote tissue healing. Furthermore, Zeo ScientifiX develops and distributes products containing its proprietary ingredients for topical aesthetic applications. These offerings include ZEO GROW X, a professional-grade formula delivering concentrated topical exosomes to support follicular function, as well as ZEO GROW BOOST and EXO FOLLICLE FUEL. Founded in 2011, the company was formerly known as Organicell Regenerative Medicine, Inc. before rebranding to Zeo ScientifiX, Inc. in February 2024. It is headquartered in Davie, Florida.
Technical Analysis
Imunon
―
XTL Biopharmaceuticals Sponsored ADR
―
Marker Therapeutics
―
Dogwood Therapeutics
―
AEON Biopharma
―
Ownership Overview
Options Prices
Currently, No data available
---